Taiwan FDA registration 140f4169107dae658c5951981cd056bb

"Medtronic" Intelles magnetic resonance rechargeable neurostimulator

TW: “美敦力”因特列斯磁振造影可充電神經刺激器
Taiwan flagTaiwan·Risk Class 3·Medtronic Puerto Rico Operations Co., Juncos;; Medtronic Inc.·Registered Apr 21, 2020 – Apr 21, 2030Active
Registration details
Analysis ID
140f4169107dae658c5951981cd056bb
Customs Code
DHA05603340400
Company information
Manufacturer Country
United States
Authorized Representative
MEDTRONIC (TAIWAN) LTD.
Product details
Intended Use
The Intellis SCS Neurostimulation System is indicated for chronic intractable pain in the auxiliary tubes, trunk and/or extremities. ●Patients with stable intractable angina that is ineffective or unsuitable for revascularization after medical therapy or revascularization. ●Patients with stable refractory peripheral vascular disease classified as stage 2 or above and who are not candidates for revascularization.
Product Type (Level 1)
K Neuroscience
Product Type (Level 2)
K.5880 Implantable spinal cord stimulator for pain relief
Import Information
import
Dates and status
Registration Date
Apr 21, 2020
Expiry Date
Apr 21, 2030
About this record

Access comprehensive regulatory information for "Medtronic" Intelles magnetic resonance rechargeable neurostimulator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 140f4169107dae658c5951981cd056bb and manufactured by Medtronic Puerto Rico Operations Co., Juncos;; Medtronic Inc.. The authorized representative in Taiwan is MEDTRONIC (TAIWAN) LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices